pCEA	polyclonal carcinoembryonic antigen
MTR-1-P	methylthioribose-1-phosphate
ODC	ornithine deacrboxylase
SAM	S-adenosylmethionine
DUB	deubiquitinating enzyme
YY1-Ying	Yang 1 transcriptional repressor
FOXK1/2	forkhead transcription factor
HCF-1	host cell factor 1
BARD1	BRCA1-associated RING domain protein 1
PRMT5	protein arginine methyltransferase
MAT2A	metabolic enzyme methionine adenosyltransferase II alpha
SDMA	symmetric demethylation of arginine
ASXL1/2	additional sex comb like 1 or 2
OGT	O-linked N-acetylglucosamine transferase
BRCA1	breast cancer gene 1
PR-DUB	polycomb group repressive deubiquitinase complex
H2Aub	ubiquitinated H2A
HDAC	histone deacetylase inhibitors
ER	endoplasmic reticulum
IP3R3	type 3 inositol-1, 4, 5 -triphosphate receptor
ROS	reactive oxygen speacies
TME	tumor microenvironment
ECM	extracellular matrix
EMT	epithelial to mesenchymal transition
TGF-β	transforming growth factor-beta
SMA	smooth muscle actin
EGF	epidermal growth factor
PFS	progression-free survival
pDCs	plasmacytoid dendritic cells
PD-L1	programmed death ligand 1
OS	overall survival
CSS	cancer-specific survival
LDH	lactate dehydrogenase
MPE	malignant pleural effusion
SO2	sulfur dioxide
NO2	nitrogen dioxide
MMT	multimodal therapy
EZH2	enhancer of zeste 2 polycomb repressive complex 2
6TG	6′-tioguanine
2FA	2′-fluoroadenine